Clinical review: Anticoagulation for continuous renal replacement therapy - heparin or citrate?

Heparin is the most commonly prescribed anticoagulant for continuous renal replacement therapy. There is, however, increasing evidence questioning its safety, particularly in the critically ill. Heparin mainly confers its anticoagulant effect by binding to antithrombin. Heparin binds to numerous oth...

Descripción completa

Detalles Bibliográficos
Autores principales: Oudemans-van Straaten, Heleen M, Kellum, John A, Bellomo, Rinaldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222015/
https://www.ncbi.nlm.nih.gov/pubmed/21345279
http://dx.doi.org/10.1186/cc9358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222015/
https://www.ncbi.nlm.nih.gov/pubmed/21345279
http://dx.doi.org/10.1186/cc9358

Ejemplares similares